Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:2109-2116
Published online before print September 17, 2009, doi: 10.1161/ATVBAHA.109.194589
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/12/2109    most recent
ATVBAHA.109.194589v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Orbe, J.
Right arrow Articles by Páramo, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orbe, J.
Right arrow Articles by Páramo, J. A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:2109.)
© 2009 American Heart Association, Inc.


Cell Biology/Signaling

Matrix Metalloproteinase-10 Is Upregulated by Thrombin in Endothelial Cells and Increased in Patients With Enhanced Thrombin Generation

Josune Orbe; José A. Rodríguez; Olivier Calvayrac; Ricardo Rodríguez-Calvo; Cristina Rodríguez; Carmen Roncal; Sara Martínez de Lizarrondo; Jaione Barrenetxe; Juan C. Reverter; José Martínez-González; José A. Páramo

From the Atherothrombosis Research Laboratory, Division of Cardiovascular Sciences (J.O., J.A.R., C.R., S.M.d.L., J.B., J.A.P.), Center for Applied Medical Research (CIMA)-University of Navarra, Pamplona, Spain; Centro de Investigación Cardiovascular (CSIC-ICCC) (O.C., R.R.-C., C.R., J.M.-G.), Hospital de la Santa Creu I Sant Pau, Barcelona, Spain; the Department of Haemotherapy and Haemostasis (J.C.R.), Hospital Clinic, University of Barcelona, Spain; and the Hematology Service (J.A.P.), University Clinic, University of Navarra, Pamplona, Spain.

Correspondence to José A. Páramo, Atherothrombosis Research Laboratory, Division of Cardiovascular Science, CIMA-University of Navarra, Avda. Pio XII, 55 31008 Pamplona, Navarra, Spain. E-mail japaramo{at}unav.es José Martínez-González, Centro de Investigación Cardiovascular (CSIC-ICCC), Hospital de la Santa Creu I Sant Pau, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain. E-mail jmartinez@csic-iccc.org.

Objective— Thrombin is a multifunctional serine protease that promotes vascular proinflammatory responses whose effect on endothelial MMP-10 expression has not previously been evaluated.

Methods and Results— Thrombin induced endothelial MMP-10 mRNA and protein levels, through a protease-activated receptor-1 (PAR-1)–dependent mechanism, in a dose- and time-dependent manner. This effect was mimicked by a PAR-1 agonist peptide (TRAP-1) and antagonized by an anti–PAR-1 blocking antibody. MMP-10 induction was dependent on extracellular regulated kinase1/2 (ERK1/2) and c-jun N-terminal kinase (JNK) pathways. By serial deletion analysis, site-directed mutagenesis and electrophoretic mobility shift assay an AP-1 site in the proximal region of MMP-10 promoter was found to be critical for thrombin-induced MMP-10 transcriptional activity. Thrombin and TRAP-1 upregulated MMP-10 in murine endothelial cells in culture and in vivo in mouse aorta. This effect of thrombin was not observed in PAR-1–deficient mice. Interestingly, circulating MMP-10 levels (P<0.01) were augmented in patients with endothelial activation associated with high (disseminated intravascular coagulation) and moderate (previous acute myocardial infarction) systemic thrombin generation.

Conclusion— Thrombin induces MMP-10 through a PAR-1–dependent mechanism mediated by ERK1/2, JNK, and AP-1 activation. Endothelial MMP-10 upregulation could be regarded as a new proinflammatory effect of thrombin whose pathological consequences in thrombin-related disorders and plaque stability deserve further investigation.

Thrombin can interact with extracellular matrix components and promote vascular proinflammatory responses including MMP upregulation. We show that thrombin induces endothelial MMP-10, in vitro and in vivo, through a PAR-1–dependent mechanism mediated by ERK1/2, JNK, and AP-1 activation. Increased MMP-10 can be observed in pathologies with augmented thrombin generation.


Key Words: thrombin • endothelium • MMP-10 • atherosclerosis • thrombosis